SciClone Pharmaceuticals

SciClone is a US-based, China-focused specialty pharmaceutical company with a substantial revenue-generating and profitable commercial business and a broad, marketed product portfolio of differentiated therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders.

Type
Public
HQ
Foster City, US
Founded
1989
Size (employees)
570 (est)-3%
SciClone Pharmaceuticals was founded in 1989 and is headquartered in Foster City, US

SciClone Pharmaceuticals Office Locations

SciClone Pharmaceuticals has an office in Foster City
Foster City, US (HQ)
900 950 Tower Ln

SciClone Pharmaceuticals Metrics

SciClone Pharmaceuticals Financial Metrics

SciClone Pharmaceuticals's revenue was reported to be $160.1 m in 2016

Revenue (Y, 2016)

$160.1 m

Revenue growth (Y, 2015 - Y, 2016), %

2%

Gross profit (Y, 2016)

$137.2 m

Gross profit margin (Y, 2016), %

86%

Net income (Y, 2016)

$30.7 m

EBIT (Y, 2016)

$33.2 m

Market capitalization (22-May-2017)

$486.3 m

Closing share price (22-May-2017)

$9.5

Cash (31-Dec-2016)

$134.4 m
SciClone Pharmaceuticals's current market capitalization is $486.3 m.
FY, 2013FY, 2014FY, 2015Y, 2016

Revenue

$127.1 m$134.8 m$157.3 m$160.1 m

Revenue growth, %

6%17%2%

Cost of goods sold

$22.3 m$22.9 m

Gross profit

$134.9 m$137.2 m

Gross profit Margin, %

86%86%

Operating expense total

$127.3 m$126.9 m

EBIT

$10.4 m$26 m$29.9 m$33.2 m

EBIT margin, %

8%19%19%21%

Net Income

$11 m$25.2 m$29.5 m$30.7 m
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$85.8 m$86.2 m$101.4 m$134.4 m

Accounts Receivable

$40.3 m

Inventories

$15.2 m$10.7 m$11 m$16.6 m

Current Assets

$143.4 m$140.2 m$168.5 m$195.7 m

PP&E

$843 k$1.8 m$2.7 m$2 m

Goodwill

$35.4 m$34.5 m$33 m$30.8 m

Total Assets

$180.2 m$181.8 m$216.6 m$241.9 m

Accounts Payable

$7.2 m$5.3 m$4.5 m$3.6 m

Current Liabilities

$33.6 m$26.4 m$36.8 m$26.4 m

Additional Paid-in Capital

$278.3 m$287.1 m$296.1 m$304.6 m

Retained Earnings

($136 m)($135.1 m)($118.5 m)($87.8 m)

Total Equity

$146.6 m$155.3 m$179.7 m$215.4 m

Financial Leverage

1.2 x1.2 x1.2 x1.1 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$11 m$25.2 m$29.5 m$30.7 m

Depreciation and Amortization

$860 k$852 k$931 k$985 k

Accounts Receivable

($4.2 m)($3.3 m)$306 k($2.4 m)

Inventories

($4.7 m)$5.9 m$1.4 m($3 m)

Accounts Payable

($652 k)($5.5 m)($2.3 m)($3.1 m)

Cash From Operating Activities

$9.5 m$27.6 m$32.5 m$34.5 m

Purchases of PP&E

($324 k)($1.5 m)($1.8 m)($648 k)

Cash From Investing Activities

$55 k($6.2 m)($9 m)($3.4 m)

Cash From Financing Activities

($8.4 m)($20.8 m)($8.4 m)$1.9 m
Y, 2016

Revenue/Employee

$271.3 k

Financial Leverage

1.1 x

SciClone Pharmaceuticals Market Value History

SciClone Pharmaceuticals Company Life

You may also be interested in